Markets Nosedive

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

RBI's May Review

RBI's May Review

Subbarao overrules panel view on rate action in May.  Full Article 

SBI Earnings

SBI Earnings

State Bank of India Q4 profit falls, shares drop.  Full Article | Related Story 

Bernanke Impact

Bernanke Impact

U.S. Fed enters delicate new phase of communication  Full Article | Column 

Subsidy Compensation

Subsidy Compensation

Government to pay state-run fuel retailers $8.1 billion in Q4 oil subsidy.  Full Article 

Ranbaxy Accusation

Ranbaxy Accusation

Daiichi Sankyo accusation "false and baseless": Singhs  Full Article 

Tata Steel Results

Tata Steel Results

Tata Steel reports loss on Europe weakness.  Full Article 

FDA Woes

FDA Woes

Wockhardt says FDA alert affects potential sales of $100 million.  Full Article 

Goldman Safeguards

Goldman Safeguards

Battle-scarred Goldman CEO unveils safeguards to avoid mistakes  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Govt likely to infuse $544 mln in FY13: SBI head

Related Topics

Stocks

   
Track BSE Sectoral Indices

Track Markets: BSE Sectoral Indices

Track and analyse performance of all BSE sectoral indices and other global indices on a single page.   Full Coverage 

People walk in front of a signboard displayed at the head office of State Bank of India in Mumbai November 9, 2009. REUTERS/Arko Datta/Files

People walk in front of a signboard displayed at the head office of State Bank of India in Mumbai November 9, 2009.

Credit: Reuters/Arko Datta/Files

NEW DELHI | Mon Jan 7, 2013 2:42pm IST

NEW DELHI (Reuters) - The government has indicated a capital infusion of 30 billion rupees into State Bank of India in the current fiscal year ending in March 2013, the bank's chairman said on Monday.

The infusion into the country's biggest bank will be done through a preferential allotment of shares, Pratip Chaudhury told reporters.

Capital infusion plans for the next financial year have not been finalised yet, Chaudhury added.

(Reporting by Arup Roychoudhury; Editing by Sunil Nair)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.